Executive Summary: Society of Critical Care Medicine Guidelines for the Administration of Neuromuscular Blockade in Adults With Acute Respiratory Distress Syndrome

By afschroeder • March 4, 2026

Erstad BL, Cobas MA, Qadir N, Alshamsi F, Sharif S, Devine EM, Devine ST, Einav S, Elmer J, Fort AC, Harrod CG, Heavner MS, Lamb KD, Mehta S, Mitchell DA, Paruk F, Piraino T, Sacha G, Schell-Chaple HM, Sinha S, Smith SE, Topeli A, Sarwal A. Executive Summary: Society of Critical Care Medicine Guidelines for the Administration of Neuromuscular Blockade in Adults With Acute Respiratory Distress Syndrome. Crit Care Med. 2026 Mar 1;54(3):630-633. doi: 10.1097/CCM.0000000000007001. Epub 2026 Mar 3. PMID: 41773928.

Tags: acute respiratory distress syndrome, critical care, critical illness, Intensive Care Unit, neuromuscular blocking agents, practice guideline, Publications, Pulmonary, Critical Care & Sleep Medicine

Eosinophilic cholangitis as an indeterminate biliary mimic: A systematic review of outcomes

Stirrat T, Wilkey M, Ransibrahmanakul V, Singh L, Allen O, Kanth P, Rangnekar A, Redfield R. Eosinophilic cholangitis as an indeterminate biliary mimic: A systematic[...]

Real-world clinical outcomes of Trastuzumab Deruxtecan in HER2-expressing ovarian and endometrial Cancer

Silverstein J, Alomaja O, Chatram D, Hajiabbasi M, Shachar E, Tseng CH, Thaker S, Bardia A, Karlan B, Hendrickson AW, Konecny GE. Real-world clinical outcomes[...]

Fixed-duration epcoritamab plus R-CHOP in newly diagnosed LBCL with IPI score 3-5: results from the EPCORE NHL-2 trial

Falchi L, Offner F, de Vos S, Brody JD, Morillo D, Linton K, Snauwaert S, Roost Clausen M, Karimi YH, Thieblemont C, Vitolo U, Leslie[...]